The Primary
Care Companionfor CNS Disorders

Volume 14 • 2012 • 6

Article

Improvement in Functional Outcomes With Adjunctive Aripiprazole Versus Placebo in Major Depressive Disorder: A Pooled Post Hoc Analysis of 3 Short-Term Studies

Prim Care Companion CNS Disord 2012;14(6):doi:10.4088/PCC.12m01394

James M. Eudicone, MS, MBA; Robert A. Forbes, PhD; Robert M. Berman, MD; Ross A. Baker, PhD, MBA; Linda M. Rollin, PhD; Tanya J. Fabian, PharmD, PhD; Zachary J. Cain, PharmD; Diane Ammerman, PharmD; Yan Tang, MS

Article

A Survey of Sleep Quality in Patients With 13 Types of Mental Disorders

Prim Care Companion CNS Disord 2012;14(6):doi:10.4088/PCC.11m01173

Cui Lijun, MD; Li Ke-qing, PhD; Sun Xiuli, MD; Cui Ze, MD; Jiang Qinpu, MD; Han Yanchao, MD; Gao Lianghui, MD; Zhang Yang, MD; Li Jianfeng, MD; Liu Yongqiao, MD; Yang Laohu, MD; Lv Hua, MD

Article

Collaborative Care for the Treatment of Depression in Primary Care With a Low-Income, Spanish-Speaking Population: Outcomes From a Community-Based Program Evaluation

Prim Care Companion CNS Disord 2012;14(6):doi:10.4088/PCC.12m01385

Katherine Sanchez, LCSW, PhD; Toni Terling Watt, PhD

Article

Assessing Treatment Outcomes in Attention-Deficit/Hyperactivity Disorder: A Narrative Review

Prim Care Companion CNS Disord 2012;14(6):doi:10.4088/PCC.11r01336

Margaret D. Weiss, MD, PhD, FRCP(C); Jeffery N. Epstein, PhD

Article

Beneficial Effects of Adjunctive Aripiprazole in Major Depressive Disorder Are Not Dependent on Antidepressant Therapy History: A Post Hoc Analysis of 3 Randomized, Double-Blind, Placebo-Controlled Trials

Prim Care Companion CNS Disord 2012;14(6):doi:10.4088/PCC.12m01380

David L. Dunner, MD, FACPsych; Robert A. Forbes, PhD; Robert M. Berman, MD; Ross A. Baker, PhD; Kimberly K. Laubmeier, PhD; George Manos, PhD

Article

Importance of Gender in the Treatment of Schizophrenia

Prim Care Companion CNS Disord 2012;14(6):doi:10.4088/PCC.12m01407

Eva Ceskova, MD; Radovan Prikryl, MD

Article

Depression, Quality of Life, Work Productivity, Resource Use, and Costs Among Women Experiencing Menopause and Hot Flashes: A Cross-Sectional Study

Prim Care Companion CNS Disord 2012;14(6):doi:10.4088/PCC.12m01410

Jose Alvir, DrPH; Marco daCosta DiBonaventura, PhD; Jan-Samuel Wagner, BS; Jennifer Whiteley, EdD

Rounds from Banner Alzheimer's Institute

Delayed Cognitive Impairment After a Hypoxic Event

Prim Care Companion CNS Disord 2012;14(6):doi:10.4088/PCC.12alz01491

Roy Yaari, MD, MAS; Adam S. Fleisher, MD, MAS; Pierre N. Tariot, MD; Helle Brand, PA; James D. Seward, PhD, ABPP; Anna D. Burke, MD

Psychotherapy Casebook

Grieving the Loss of a Friend

Prim Care Companion CNS Disord 2012;14(6):doi:10.4088/PCC.12f01470

Dean Schuyler, MD

Brief Report

Beneficial Effects of the Sigma-1 Agonist Fluvoxamine for Tardive Dyskinesia in Patients With Postpsychotic Depressive Disorder of Schizophrenia: Report of 5 Cases

Prim Care Companion CNS Disord 2012;14(6):doi:10.4088/PCC.12br01401

Kenji Hashimoto, PhD; Yakup Albayrak, MD

Letter to the Editor

Litigious History and Borderline Personality Symptomatology

Prim Care Companion CNS Disord 2012;14(6):doi:10.4088/PCC.11l01325

Randy A. Sansone, MD; Michael W. Wiederman, PhD; Justin S. Leung, BA

Letter to the Editor

Serotonin Syndrome in a Sertraline-Treated Man Taking NyQuil Containing Dextromethorphan for Cold

Prim Care Companion CNS Disord 2012;14(6):doi:10.4088/PCC.12l01388

Roopa Sethi, MD; Bush Kavuru, MD; Anita S. Kablinger, MD

Letter to the Editor

Can Using a Detoxification Kit Result in Bizarre Behavior and Hallucinations?

Prim Care Companion CNS Disord. 2012;14(6):doi:10.4088/PCC.12lr01366

Nasim Zamani, MD

Letter to the Editor

Dr Mittal and Colleagues Reply

Prim Care Companion CNS Disord. 2012;14(6):doi:10.4088/PCC.12lr01366a

Ahsan Y. Khan, MD; Moneeshindra Singh Mittal, MD; Rachna Kalia, MD

Letter to the Editor

Olanzapine-Associated Leukopenia and Thrombocytopenia Managed With Lithium in a Patient Who Developed Leukopenia With Clozapine in the Past: A Case Report

Prim Care Companion CNS Disord 2012;14(6):doi:10.4088/PCC.12l01367

Sandeep Grover, MD; Aditya Hegde, MBBS; Munish Agarwal, MD; Manupdesh Singh Sachdeva, MD

Letter to the Editor

Two Instances of Improvement in Tardive Dyskinesia After Administration of Aripiprazole in a Single Patient

Prim Care Companion CNS Disord 2012;14(6):doi:10.4088/PCC.11l01315

Chih-Lun Chen, MD; Han-Wei Chou, MD

Letter to the Editor

Amphetamine Use as a Risk Factor for Low-Dose Risperidone-Induced Acute Dystonia: A Case Report

Prim Care Companion CNS Disord 2012;14(6):doi:10.4088/PCC.12l01397

Pierre Landry, MD, PhD, FRCPC; Isabelle Michaud, MD

Letter to the Editor

Successful Use of Oxazepam in the Treatment of Delirium Tremens

Prim Care Companion CNS Disord 2012;14(6):doi:10.4088/PCC.12l01404

Suresh Bada Math, MD, DNB, PGDMLE, PGDMLE; Janardhanan C. Narayanaswamy, MD; Biju Viswanath, MD; Kavita Nagpal, MBBS; Srinath Gopinath, MBBS, DPM; C. R. Chandrasekhar, MD

Letter to the Editor

Beneficial Effects of Fluvoxamine for Chorea in a Patient With Huntington's Disease: A Case Report

Prim Care Companion CNS Disord 2012;14(6):doi:10.4088/PCC.12l01369

Yakup Albayrak, MD; Görkem Karakaş Uğurlu, MD; Mustafa Uğurlu, MD; Ali Çayköylü, MD

Volume 14 • 2012 • 6

Article

Improvement in Functional Outcomes With Adjunctive Aripiprazole Versus Placebo in Major Depressive Disorder: A Pooled Post Hoc Analysis of 3 Short-Term Studies

A Survey of Sleep Quality in Patients With 13 Types of Mental Disorders

Collaborative Care for the Treatment of Depression in Primary Care With a Low-Income, Spanish-Speaking Population: Outcomes From a Community-Based Program Evaluation

Assessing Treatment Outcomes in Attention-Deficit/Hyperactivity Disorder: A Narrative Review

Beneficial Effects of Adjunctive Aripiprazole in Major Depressive Disorder Are Not Dependent on Antidepressant Therapy History: A Post Hoc Analysis of 3 Randomized, Double-Blind, Placebo-Controlled Trials

Importance of Gender in the Treatment of Schizophrenia

Depression, Quality of Life, Work Productivity, Resource Use, and Costs Among Women Experiencing Menopause and Hot Flashes: A Cross-Sectional Study

Rounds from Banner Alzheimer's Institute

Delayed Cognitive Impairment After a Hypoxic Event

Psychotherapy Casebook

Grieving the Loss of a Friend

Brief Report

Beneficial Effects of the Sigma-1 Agonist Fluvoxamine for Tardive Dyskinesia in Patients With Postpsychotic Depressive Disorder of Schizophrenia: Report of 5 Cases

Letter to the Editor

Litigious History and Borderline Personality Symptomatology

Serotonin Syndrome in a Sertraline-Treated Man Taking NyQuil Containing Dextromethorphan for Cold

Can Using a Detoxification Kit Result in Bizarre Behavior and Hallucinations?

Dr Mittal and Colleagues Reply

Olanzapine-Associated Leukopenia and Thrombocytopenia Managed With Lithium in a Patient Who Developed Leukopenia With Clozapine in the Past: A Case Report

Two Instances of Improvement in Tardive Dyskinesia After Administration of Aripiprazole in a Single Patient

Amphetamine Use as a Risk Factor for Low-Dose Risperidone-Induced Acute Dystonia: A Case Report

Successful Use of Oxazepam in the Treatment of Delirium Tremens

Beneficial Effects of Fluvoxamine for Chorea in a Patient With Huntington's Disease: A Case Report

ELSEWHERE:

FOLLOW US:

Volume 14 • 2012 • 6

Article

Improvement in Functional Outcomes With Adjunctive Aripiprazole Versus Placebo in Major Depressive Disorder: A Pooled Post Hoc Analysis of 3 Short-Term Studies

A Survey of Sleep Quality in Patients With 13 Types of Mental Disorders

Collaborative Care for the Treatment of Depression in Primary Care With a Low-Income, Spanish-Speaking Population: Outcomes From a Community-Based Program Evaluation

Assessing Treatment Outcomes in Attention-Deficit/Hyperactivity Disorder: A Narrative Review

Beneficial Effects of Adjunctive Aripiprazole in Major Depressive Disorder Are Not Dependent on Antidepressant Therapy History: A Post Hoc Analysis of 3 Randomized, Double-Blind, Placebo-Controlled Trials

Importance of Gender in the Treatment of Schizophrenia

Depression, Quality of Life, Work Productivity, Resource Use, and Costs Among Women Experiencing Menopause and Hot Flashes: A Cross-Sectional Study

Rounds from Banner Alzheimer's Institute

Delayed Cognitive Impairment After a Hypoxic Event

Psychotherapy Casebook

Grieving the Loss of a Friend

Brief Report

Beneficial Effects of the Sigma-1 Agonist Fluvoxamine for Tardive Dyskinesia in Patients With Postpsychotic Depressive Disorder of Schizophrenia: Report of 5 Cases

Letter to the Editor

Litigious History and Borderline Personality Symptomatology

Serotonin Syndrome in a Sertraline-Treated Man Taking NyQuil Containing Dextromethorphan for Cold

Can Using a Detoxification Kit Result in Bizarre Behavior and Hallucinations?

Dr Mittal and Colleagues Reply

Olanzapine-Associated Leukopenia and Thrombocytopenia Managed With Lithium in a Patient Who Developed Leukopenia With Clozapine in the Past: A Case Report

Two Instances of Improvement in Tardive Dyskinesia After Administration of Aripiprazole in a Single Patient

Amphetamine Use as a Risk Factor for Low-Dose Risperidone-Induced Acute Dystonia: A Case Report

Successful Use of Oxazepam in the Treatment of Delirium Tremens

Beneficial Effects of Fluvoxamine for Chorea in a Patient With Huntington's Disease: A Case Report

Learn More About Ketamine and Psychedelics

Subscribe to readmore articles

Subscribe to read
more articles